From Reactive Care to Predictive Pharma: Indian AI Shift by 2026
India’s pharmaceutical industry is transitioning from a reactive, volume-driven model to a predictive, AI-powered ecosystem—highlighting the role of agentic AI, smart manufacturing, resilient supply chains and personalised medicine in shaping a high-value, patient-centric pharma future by 2026.
Tushar Dhawan | 02/01/2026
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy